A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

A Prospective Multi-Institutional Phase I/II Trial of Step-Wise Dose-per-Fraction Escalation in Low and Intermediate Risk Prostate Cancer

Published:2020-09 Issue:5 Volume:10 Page:345-353
ISSN:1879-8500
Container-title:Practical Radiation Oncology
language:en
Short-container-title:Practical Radiation Oncology

Author:

Ritter Mark A.,Kupelian Patrick A.,Petereit Daniel G.,Lawton Colleen A.,Anger Nick,Geye Heather,Chappell Richard J.,Forman Jeffrey D.

Funder

National Cancer Institute

National Institutes of Health

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology

Reference32 articles.

1. The alpha/beta ratio for prostate cancer: What is it, really?;Bentzen;Radiother Oncol,2005

2. Fractionation and protraction for radiotherapy of prostate carcinoma;Brenner;Int J Radiat Oncol Biol Phys,1999

3. Is alpha/beta for prostate tumors really low?;Fowler;Int J Radiat Oncol Biol Phys,2001

4. Randomized trial of a hypofractionated radiation regimen for the treatment of localized prostate cancer;Catton;J Clin Oncol,2017

5. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial;Dearnaley;Lancet Oncol,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The expanding role of radiation oncology across the prostate cancer continuum;Abdominal Radiology;2024-06-20

2. Long-Term Outcomes of a Prospective Study on Highly Hypofractionated Intensity Modulated Radiation Therapy for Localized Prostate Cancer for 3 Weeks;Practical Radiation Oncology;2023-11

3. Analysis of the EPAS-1 Expression Level and Pathological Characteristics of Renal Cell Carcinoma;Pakistan Journal of Zoology;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3